Lombardi Marco, Chiabrando Juan G, Romagnoli Enrico, D'Amario Domenico, Leone Antonio M, Aurigemma Cristina, Montone Rocco A, Ricchiuto Alfredo, Biondi-Zoccai Giuseppe, Burzotta Francesco, Jang Ik-Kyung, Escaned Javier, Trani Carlo, Porto Italo, Crea Filippo, Vergallo Rocco
Department of Cardiovascular and Pulmonary Sciences, Università Cattolica del Sacro Cuore, Rome, Italy.
Interventional Cardiology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Minerva Cardiol Angiol. 2023 Oct;71(5):525-534. doi: 10.23736/S2724-5683.22.06185-3. Epub 2023 Mar 13.
The association of coronary stent malapposition (SM) and adverse clinical outcomes after percutaneous coronary intervention (PCI) remains unclear. We aimed to perform a systematic review and meta-analysis of randomized and observational studies to assess the association between acute and persistent SM detected using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) and adverse cardiovascular outcomes.
Available studies were identified through a systematic search of PubMed, reference lists of relevant articles, and Medline. Main efficacy outcomes of interest were: device-oriented composite endpoint (DoCE, including cardiac death, myocardial infarction [MI], target lesion revascularization [TLR], and stent thrombosis [ST]), major safety events (MSE, including cardiac death, MI and ST), TLR, and ST. A sensitivity analysis regarding the impact of major malapposition was also performed.
A total of 9 studies enrolling 6497 patients were included in the meta-analysis. After a mean follow-up of 24±14 months, overall acute and/or persistent malapposition was not significantly associated with the occurrence of all the outcomes of interest, including DoCE (risk ratio [RR] 1.00, 95% confidence interval [CI, 0.79-1.26], P=0.99), MSE (RR 1.42, 95%CI [0.81-2.50], P=0.22), TLR (RR 0.84, 95%CI [0.59-1.19], P=0.33), and ST (RR 1.16, 95%CI [0.48-2.85], P=0.74). In the sensitivity analysis, we found a significant increase of MSE in patients with major malapposition (RR 2.97, 95%CI [1.51-5.87], P=0.001).
Acute and persistent SM were not overall associated with adverse cardiovascular clinical outcomes at follow-up. However, major malapposition was associated with an increased risk of major safety events, including cardiac death, MI and ST. These findings should be taken into account during stent implantation and PCI optimization.
经皮冠状动脉介入治疗(PCI)后冠状动脉支架贴壁不良(SM)与不良临床结局之间的关联尚不清楚。我们旨在对随机和观察性研究进行系统评价和荟萃分析,以评估使用血管内超声(IVUS)或光学相干断层扫描(OCT)检测到的急性和持续性SM与不良心血管结局之间的关联。
通过系统检索PubMed、相关文章的参考文献列表和Medline来确定可用的研究。感兴趣的主要疗效结局包括:器械导向复合终点(DoCE,包括心源性死亡、心肌梗死[MI]、靶病变血运重建[TLR]和支架血栓形成[ST])、主要安全事件(MSE,包括心源性死亡、MI和ST)、TLR和ST。还进行了关于严重贴壁不良影响的敏感性分析。
荟萃分析共纳入9项研究,涉及6497例患者。平均随访24±14个月后,总体急性和/或持续性贴壁不良与所有感兴趣的结局的发生均无显著关联,包括DoCE(风险比[RR]1.00,95%置信区间[CI,0.79 - 1.26],P = 0.99)、MSE(RR 1.42,95%CI[0.81 - 2.50],P = 0.22)、TLR(RR 0.84,95%CI[0.59 - 1.19],P = 0.33)和ST(RR 1.16,95%CI[0.48 - 2.85],P = 0.74)。在敏感性分析中,我们发现严重贴壁不良患者的MSE显著增加(RR 2.97,95%CI[1.51 - 5.87],P = 0.001)。
随访时急性和持续性SM总体上与不良心血管临床结局无关。然而,严重贴壁不良与包括心源性死亡、MI和ST在内的主要安全事件风险增加有关。在支架植入和PCI优化过程中应考虑这些发现。